XOR-mediated tumor-selective nanomaterial therapy: achieving tumor and immune cell dual regulation through intracellular ROS generation

Key Points

• This research aims to explore a novel nanomaterial for gastric cancer immunotherapy.
• Developed a new nanomaterial targeting tumor cells and immune response.
• Investigated the effects of the nanomaterial on intracellular ROS generation.
• Conducted in vitro and in vivo assessments of therapeutic outcomes.
• The nanomaterial selectively targeted tumor cells.
• Dual regulation of tumor and immune cells was achieved.
• Enhanced effectiveness in gastric cancer treatments observed.